Expert Review of Anticancer Therapy
Journal formatting to fit the target journal guidelines
Experts ensure all elements of your paper match journal formatting guidelines to improve publication success rate!
Aims and Scope
Expert Review of Anticancer Therapy is a monthly peer-reviewed medical journal covering all clinical aspects of cancer therapy. It was established in 2001 and is published by Taylor & Francis under the academic publishing division of Informa. The current Editor-in-Chief is Gertjan J L Kaspers who is Head of Pediatric Oncology at VU University Medical Center Amsterdam. According to Journal Citation Reports, the journal has a 2019 impact factor of 3.573. Less
Key Metrics
View Chart Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
SJR
- PublisherTAYLOR & FRANCIS LTD
- LanguageEnglish
- FrequencyMonthly
- LanguageEnglish
- FrequencyMonthly
- Publication Start Year2000
- Publisher URL
- Website URL
Ready to spotlight your research findings?
Impress peers and journals alike with a concise, visual summary of your work.
Meets Top Publisher Standards: Essential for leading journals like Elsevier.Enhances Engagement: Research papers with graphical abstracts receive 3X more downloads and 8X more shares.Tailored Just for You: We’ll create a custom graphical abstract based on your manuscript—no sketches needed.
3000+ graphical abstracts produced with 4.8/5 customer rating | Months | % Papers published |
|---|---|
| 0-3 | 31% |
| 4-6 | 51% |
| 7-9 | 12% |
| >9 | 6% |
Topics Covered
Year-wise Publication
- 5Y
- 10Y
FAQs
Since when has Expert Review of Anticancer Therapy been publishing? 
The Expert Review of Anticancer Therapy has been publishing since 2000 till date.
How frequently is the Expert Review of Anticancer Therapy published?
Expert Review of Anticancer Therapy is published Monthly.
What is the H-index. SNIP score, Citescore and SJR of Expert Review of Anticancer Therapy?
Expert Review of Anticancer Therapy has a H-index score of 79, Citescore of 6.7, SNIP score of 1.08, & SJR of Q2
Who is the publisher of Expert Review of Anticancer Therapy?
The publisher of Expert Review of Anticancer Therapy is TAYLOR & FRANCIS LTD.
Where can I find a journal's aims and scope of Expert Review of Anticancer Therapy?
For the Expert Review of Anticancer Therapy's Aims and Scope, please refer to the section above on the page.
How can I view the journal metrics of Expert Review of Anticancer Therapy on editage?
For the Expert Review of Anticancer Therapy metrics, please refer to the section above on the page.
What is the eISSN and pISSN number of Expert Review of Anticancer Therapy?
The eISSN number is 1744-8328 and pISSN number is 1473-7140 for Expert Review of Anticancer Therapy.
What is the focus of this journal?
The journal covers a wide range of topics inlcuding Cancer, Lung cancer, Breast cancer, Lymph node, Systematic review, Immunotherapy, Chemoradiotherapy, Hepatocellular carcinoma, Neuroendocrine tumors, Toxicity, Epidermal growth factor receptor, Pediatric acute myeloid leukemia, Thyroid cancer, Trastuzumab emtansine, Prostate cancer, Clinical trial, Systemic therapy, Platinum, Tumor microenvironment, Toxicity profile.
Why is it important to find the right journal for my research?
Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.
Can the choice of journal affect my academic career?
Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.
Is it advisable to target high-impact journals only?
While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.